Holen Sie sich die Stockscreener-App
2.635
27.88%
0.555
Schlusskurs vom Vortag:
$2.08
Offen:
$2.24
24-Stunden-Volumen:
3.72M
Relative Volume:
8.52
Marktkapitalisierung:
$161.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.86M
KGV:
-2.3527
EPS:
-1.12
Netto-Cashflow:
$-55.66M
1W Leistung:
+43.01%
1M Leistung:
+26.07%
6M Leistung:
+69.43%
1J Leistung:
+64.20%
1-Tages-Spanne:
$2.23
$2.69
1-Wochen-Bereich:
$1.76
$3.01
52-Wochen-Spanne:
$0.8551
$3.01
Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile
Firmenname
Acumen Pharmaceuticals Inc
Sektor
Branche
Telefon
617-344-4190
Adresse
1210-1220 WASHINGTON STREET, NEWTON
Vergleichen Sie ABOS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals Inc
|
2.66 | 125.99M | 0 | -64.86M | -55.66M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.51 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
769.33 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
865.47 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
355.62 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.25 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-17 | Eingeleitet | Citigroup | Buy |
| 2024-07-26 | Eingeleitet | Citigroup | Buy |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-07-20 | Fortgesetzt | BofA Securities | Buy |
| 2023-05-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-07-15 | Eingeleitet | BTIG Research | Buy |
| 2022-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-07-26 | Eingeleitet | BofA Securities | Neutral |
| 2021-07-26 | Eingeleitet | Credit Suisse | Outperform |
| 2021-07-26 | Eingeleitet | Stifel | Buy |
| 2021-07-26 | Eingeleitet | UBS | Buy |
Alle ansehen
Acumen Pharmaceuticals Inc Aktie (ABOS) Neueste Nachrichten
Acumen Pharmaceuticals (NASDAQ:ABOS) Price Target Raised to $7.00 at BTIG Research - MarketBeat
Baker Hughes To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Acumen Pharmaceuticals’ Share Volatility: Insight Into Recent Developments - StocksToTrade
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Does Sabirnetug’s Phase 2 Extension and Insider Stock Sales Alter the Bull Case for ABOS? - Yahoo Finance
Acumen Pharma CFO Zuga sells shares worth $7.6k By Investing.com - Investing.com Canada
Acumen Pharmaceuticals CLO sells shares worth $16,720 By Investing.com - Investing.com Nigeria
Acumen Pharmaceuticals CEO sells shares worth $21993 By Investing.com - Investing.com India
Acumen Pharma CMO Siemers sells $5.8k in ABOS stock By Investing.com - Investing.com Canada
Acumen Pharmaceuticals CEO sells shares worth $21993 - Investing.com
Daniel Joseph Oconnell Sells 9,346 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - MarketBeat
Acumen Pharmaceuticals CLO sells shares worth $16,720 - Investing.com
"Study Within A Study" Reveals Best Recruitment Strategies For Alzheimer's Trials - Clinical Leader
VIX Spike: How does Acumen Pharmaceuticals Inc perform in inflationary periods2025 Technical Overview & Smart Swing Trading Techniques - baoquankhu1.vn
EV Market: What is the earnings history of Acumen Pharmaceuticals IncQuarterly Performance Summary & Low Drawdown Momentum Ideas - baoquankhu1.vn
Acumen Pharmaceuticals Inc. (ABOS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Daniel Joseph Oconnell Sells 12,941 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - Defense World
Acumen Pharma COO Barton sells $6.5k in shares By Investing.com - Investing.com UK
Meisner, Acumen Pharmaceuticals CLO, sells $91k in ABOS stock By Investing.com - Investing.com Nigeria
Acumen Pharma CEO O’Connell sells $47k in shares By Investing.com - Investing.com Canada
Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Daniel Joseph Oconnell Sells 12,941 Shares - MarketBeat
Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Sells $14,820.26 in Stock - MarketBeat
Insider Selling: Acumen Pharmaceuticals (NASDAQ:ABOS) CFO Sells 6,888 Shares of Stock - MarketBeat
Meisner, Acumen Pharmaceuticals CLO, sells $91k in ABOS stock - Investing.com
Acumen Pharmaceuticals, Inc Updates Corporate Presentation with New Data - TradingView
Acumen Pharmaceuticals (NASDAQ:ABOS) Insider Sells $11,769.94 in Stock - Defense World
Acumen Pharmaceuticals COO Barton Russell sells shares worth $4,692 - MSN
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Acumen Pharmaceuticals CFO sells shares totaling $56,619 - MSN
Acumen Pharma president Doherty sells $15k in ABOS stock - Investing.com
Acumen pharma chief regulatory officer sells $2k in shares By Investing.com - Investing.com South Africa
Acumen pharma chief regulatory officer sells $2k in shares - Investing.com
Acumen Pharma president Doherty sells $15k in ABOS stock By Investing.com - Investing.com UK
James Doherty Sells 6,467 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - MarketBeat
Will Acumen Pharmaceuticals Inc. stock outperform international peers2025 Trading Volume Trends & Breakout Confirmation Alerts - ulpravda.ru
Can Acumen Pharmaceuticals Inc. stock beat market expectations this quarterQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - ulpravda.ru
Will Acumen Pharmaceuticals Inc. stock outperform value stocks2025 Pullback Review & Fast Entry Momentum Alerts - Улправда
Can Acumen Pharmaceuticals Inc. stock maintain growth trajectoryMarket Volume Report & Smart Allocation Stock Tips - ulpravda.ru
Acumen Pharmaceuticals CLO sells $52,689 in shares By Investing.com - Investing.com UK
Eric Siemers Sells 6,834 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - MarketBeat
Acumen Pharmaceuticals (NASDAQ:ABOS) CFO Matt Zuga Sells 5,100 Shares - MarketBeat
Acumen Pharma CMO Siemers sells $21k in ABOS stock By Investing.com - Investing.com Canada
Acumen Pharmaceuticals CLO sells $52,689 in shares - Investing.com
Acumen Pharma CEO O’Connell sells $94k in shares By Investing.com - Investing.com Canada
Acumen Pharma CFO Zuga sells $29k in ABOS stock By Investing.com - Investing.com Canada
Acumen Pharmaceuticals, Inc.Common Stock (NQ: ABOS - FinancialContent
Is Acumen Pharmaceuticals Inc. stock supported by innovation pipelineRisk-Reward Ratio Analysis & Fast Profit Portfolio Plans - Улправда
Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Daniel Joseph Oconnell Sells 37,755 Shares - MarketBeat
Los Angeles Daily NewsAcumen Pharmaceuticals, Inc.Common Stock (Nasdaq:ABOS) Detailed Stock Data - FinancialContent
Acumen Pharmaceuticals chief legal officer sells shares worth $5,434 - MSN
Finanzdaten der Acumen Pharmaceuticals Inc-Aktie (ABOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Acumen Pharmaceuticals Inc-Aktie (ABOS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 23 '26 |
Sale |
1.90 |
5,633 |
10,718 |
173,999 |
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 21 '26 |
Sale |
1.81 |
2,247 |
4,063 |
180,686 |
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 22 '26 |
Sale |
1.84 |
1,054 |
1,939 |
179,632 |
| Siemers Eric | Chief Medical Officer |
Jan 21 '26 |
Sale |
1.80 |
2,331 |
4,204 |
256,266 |
| Siemers Eric | Chief Medical Officer |
Jan 22 '26 |
Sale |
1.82 |
895 |
1,629 |
255,371 |
| Zuga Matt | CFO & Chief Business Officer |
Jan 21 '26 |
Sale |
1.81 |
2,473 |
4,469 |
306,611 |
| Zuga Matt | CFO & Chief Business Officer |
Jan 22 '26 |
Sale |
1.86 |
1,687 |
3,138 |
304,924 |
| OConnell Daniel Joseph | Chief Executive Officer |
Jan 21 '26 |
Sale |
1.81 |
9,346 |
16,927 |
883,964 |
| OConnell Daniel Joseph | Chief Executive Officer |
Jan 22 '26 |
Sale |
1.88 |
2,689 |
5,066 |
881,275 |
| Barton Russell | Chief Operating Officer |
Jan 21 '26 |
Sale |
1.81 |
2,315 |
4,181 |
205,554 |
2.39%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):